Healthcare · Medical - Devices
Price
$2.05
Market Cap
$92.9M
Employees
163
Beta
1.47
Avg Volume
168,570
CEO
Robert G. Spignesi Jr.
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.
Runs with full report
Price Overview
Last updated: Jul 11, 2026 4:36pm (just now)
Current data · timestamped when a report runs
$2.05
Change · Jul 11
+0.31 (+17.82%)
Day Range
$1.73 – $2.14
52-Week Range
$1.66 – $4.94
50-Day MA
$2.01
200-Day MA
$3.04
Volume
757,868.00
Analyst Price Targets
Low
$7.00
Consensus
$7.00
High
$7.00
(2 analysts)
Share Structure
Outstanding
45,322,280.00
Float
24,787,355.00
Free Float
54.7%
Normal free float
— 54.7% of shares trade freely, ~45.3% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-1.95
Stock Price: $2.05
EPS (Diluted): -1.05
EPS (Diluted): -1.05
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
3.90
Stock Price: $2.05
Total Equity: $33.21M
Shares: 44,679,341
Total Equity: $33.21M
Shares: 44,679,341
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
-2.28
Market Cap: $92.91M
Total Debt: $18.90M
Cash: $20.03M
EBITDA: -$42.74M
Total Debt: $18.90M
Cash: $20.03M
EBITDA: -$42.74M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$133.4M
Market Cap: $92.91M
Total Debt: $18.90M
Cash: $20.03M
Total Debt: $18.90M
Cash: $20.03M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
3.86
Stock Price: $2.05
Revenue: $33.59M
Shares: 44,679,341
Revenue: $33.59M
Shares: 44,679,341
EV/Sales (Total value vs revenue — works when P/E can't)
API3.97
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
22.7%
Gross Profit: $7.61M
Revenue: $33.59M
Revenue: $33.59M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-141.1%
Operating Income: -$47.39M
Revenue: $33.59M
Revenue: $33.59M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-140.3%
Net Income: -$47.12M
Revenue: $33.59M
Revenue: $33.59M
ROE (Profit from shareholder equity)
APINet Income / Total Equity
-131.5%
Net Income: -$47.12M
Total Equity: $33.21M
Total Equity: $33.21M
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
-111.3%
Operating Income: -$47.39M
Tax Rate: -0.1%
Equity: $33.21M
Total Debt: $18.90M
Cash: $20.03M
Tax Rate: -0.1%
Equity: $33.21M
Total Debt: $18.90M
Cash: $20.03M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
3.31
Current Assets: $61.17M
Current Liabilities: $18.49M
Current Liabilities: $18.49M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.57
Short-Term Debt: $0.00
Long-Term Debt: $18.90M
Total Debt: $18.90M
Total Equity: $33.21M
Long-Term Debt: $18.90M
Total Debt: $18.90M
Total Equity: $33.21M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$0.75
Revenue: $33.59M
Shares: 44,679,341
Shares: 44,679,341
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$0.74
Total Equity: $33.21M
Shares: 44,679,341
Shares: 44,679,341
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-0.71
Operating CF: -$31.06M
CapEx: -$850,000
Shares: 44,679,341
CapEx: -$850,000
Shares: 44,679,341
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $2.05
Stock Price: $2.05
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$47.12M
Net Income: -$47.12M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares RPID against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $23.2M | $17.1M | $22.5M | $28.1M | $33.6M |
| Cost of Revenue | $31.0M | $25.7M | $28.0M | $28.2M | $26.0M |
| Gross Profit | -$7.7M | -$8.5M | -$5.5M | $-109,000 | $7.6M |
| Operating Expenses | $39.5M | $54.7M | $51.1M | $49.8M | $55.0M |
| Operating Income | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| Net Income | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| EBITDA | -$69.3M | -$58.5M | -$49.3M | -$43.5M | -$42.7M |
| EPS | $-1.88 | $-1.43 | $-1.22 | $-1.08 | $-1.05 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $178.4M | $27.1M | $24.3M | $16.9M | $20.0M |
| Total Current Assets | $218.1M | $138.6M | $120.4M | $80.9M | $61.2M |
| Total Assets | $241.2M | $190.7M | $143.5M | $98.2M | $74.9M |
| Current Liabilities | $18.2M | $19.1M | $19.0M | $17.6M | $18.5M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $18.9M |
| Total Liabilities | $20.2M | $26.5M | $25.5M | $22.8M | $41.6M |
| Total Equity | $221.0M | $164.2M | $118.0M | $75.4M | $33.2M |
| Retained Earnings | -$315.1M | -$375.9M | -$428.4M | -$475.3M | -$522.4M |
Cash Flow (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$55.0M | -$58.5M | -$45.1M | -$44.2M | -$31.1M |
| Capital Expenditure | -$3.2M | -$6.7M | -$1.8M | -$1.4M | $-850,000 |
| Free Cash Flow | -$58.2M | -$65.3M | -$46.9M | -$45.5M | -$31.9M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $148.5M | -$151.3M | -$2.8M | -$7.4M | $3.0M |
Analyst Estimates (Annual)
Last updated: Jul 11, 2026 2:02pm (2h ago)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$39.3M $38.5M – $40.0M
|
$46.6M $45.7M – $47.4M
|
$65.0M $63.7M – $66.1M
|
$74.7M $73.2M – $76.0M
|
| EBITDA |
-$39.3M -$40.0M – -$38.5M
|
-$46.6M -$47.4M – -$45.7M
|
-$65.0M -$66.1M – -$63.7M
|
-$74.7M -$76.0M – -$73.2M
|
| Net Income |
-$41.5M -$42.5M – -$40.5M
|
-$35.2M -$36.1M – -$34.4M
|
-$21.0M -$21.5M – -$20.5M
|
-$21.0M -$21.5M – -$20.5M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jul 11, 2026 2:02pm (2h ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | -26.3% | +31.4% | +24.6% | +19.7% |
| Gross Profit Growth | -10.3% | +35.8% | +98.0% | +7,079.8% |
| Operating Income Growth | -33.8% | +10.5% | +11.7% | +5.1% |
| Net Income Growth | +17.3% | +13.7% | +10.6% | -0.5% |
| EBITDA Growth | +15.5% | +15.7% | +11.8% | +1.8% |
Insider Trading (Recent)
Last updated: Jul 11, 2026 2:02pm (2h ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-29 | LOWENSTEIN INESE | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | LOWENSTEIN INESE | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | LOWENSTEIN INESE | A-Award | 12,787.00 | $2.34 | $29,922 |
| 2026-05-29 | PEI MELINDA LITHERLAND | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | PEI MELINDA LITHERLAND | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | PEI MELINDA LITHERLAND | A-Award | 12,787.00 | $2.34 | $29,922 |
| 2026-05-29 | Malloy Kirk | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | Malloy Kirk | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | Malloy Kirk | A-Award | 12,787.00 | $2.34 | $29,922 |
| 2026-05-29 | WIRTJES SEAN M | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | WIRTJES SEAN M | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | WIRTJES SEAN M | A-Award | 12,787.00 | $2.34 | $29,922 |
| 2026-05-29 | Spignesi Robert G. Jr. | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | Spignesi Robert G. Jr. | A-Award | 12,787.00 | $1.96 | $24,999 |
| 2026-05-29 | Spignesi Robert G. Jr. | A-Award | 12,787.00 | $2.34 | $29,922 |
| 2026-05-21 | Malloy Kirk | A-Award | 19,300.00 | $0.00 | $0 |
| 2026-05-21 | Malloy Kirk | A-Award | 38,700.00 | $2.07 | $80,109 |
| 2026-05-21 | LOWENSTEIN INESE | A-Award | 19,300.00 | $0.00 | $0 |
| 2026-05-21 | LOWENSTEIN INESE | A-Award | 38,700.00 | $2.07 | $80,109 |
| 2026-05-21 | PEI MELINDA LITHERLAND | A-Award | 19,300.00 | $0.00 | $0 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for RPID — it's generated by the pipeline (
market-narrative step).
No community reviews yet for RPID.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.406 · 9aebe10a · 2026-07-11 16:07:30